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Abstract Enhanced expression of the antioxidant stress pro- 
teins heme oxygenase-1 (HO-I) and macrophage stress protein 
(MSP23) by oxidative stress agents and oxidatively modified low 
density lipoproteins (LDL) was investigated in cultured porcine 
aortic smooth muscle cells. Treatment of smooth muscle cells with 
glucose oxidase, CdCI 2 or diethylmaleate resulted in a time-de- 
pendent (6-48 h) induction of HO-1 and MSP23 expression. 
Exposure of cells to 100 /tg protein/ml highly oxidised LDL 
increased the expression of HO-1 and MSP23 within 24 h, and 
the induction was dependent on the degree of LDL oxidation. The 
induction of HO-I and MSP23 may thus play an important 
cytoprotective role against oxidative stress in atherogenesis. 
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I. Introduction 
An imbalance between the production of reactive oxygen 
species (ROS) and cellular antioxidant defence mechanisms 
may result in oxidative stress, which has been implicated in the 
pathogenesis of several human diseases including atherosclero- 
sis [1]. Oxidatively modified low density lipoproteins (LDL) 
modulate the function of vascular cells [2], such as smooth 
muscle cells (SMC), which in atherogenesis undergo migration 
and proliferation and are thus central in the pathology of oc- 
cluding arterial lesions [3]. An investigation f the response of 
SMC to stress agents and oxidised LDL may provide further 
insights into mechanisms leading to cellular dysfunction i ath- 
erogenesis. 
The induction of intracellular antioxidant proteins may act 
as a cytoprotective defence against oxidative stress. These 
'stress' proteins include the heat shock proteins, and the most 
abundant subset hsp70 has been detected in atherosclerotic 
lesions [4] and is induced in human endothelial ceils treated with 
oxidised LDL [5]. The microsomal 32 kDa protein heme oxyge- 
nase-1 (HO-1) is another stress-induced protein, which cataly- 
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dase. 
ses the rate-limiting step in the conversion of heme via biliver- 
din and carbon monoxide to bilirubin [6], an efficient free rad- 
ical scavenger [7]. HO-I is induced by ROS, sulfhydryl-reactive 
agents, heavy metals and depletion of glutathione [8-10]. In 
murine macrophages, a cytosolic 23 kDa stress protein 
(MSP23) is induced in response to oxidative and sulfhydryl- 
reactive agents [11] and oxidised LDL [12]. The amino acid 
sequence of MSP23 is homologous with that of a family of 
stress inducible antioxidant enzymes, including the C22 compo- 
nent of alkyl hydroperoxide reductase of Salmonella ty- 
phimurium and the thiol-specific antioxidant protein of Sac- 
charomyees cerevisiae [13,14], which inhibits the inactivation of
glutamine synthetase by a thiol/Fe3*/O2 mixed function oxida- 
tion system [15]. This family of antioxidant proteins has re- 
cently been termed peroxiredoxins, asthey seem to also have 
peroxidase activity [16]. 
This study has investigated for the first time the expression 
of both HO-1 and MSP23 in cultured porcine vascular SMC 
treated with the sulfhydryl-reactive agents cadmium chloride 
and diethylmaleate (DEM), glucose oxidase (GO) or oxida- 
tively modified low density lipoproteins. 
2. Materials and methods 
2.1. Cell culture 
Porcine aortic medial explants were cultured in DMEM supple- 
mented with 10% foetal calf serum, 2 mM L-glutamine, 30 mM 
NaHCO3, 100 U/ml penicillin, I00/~g/ml streptomycin in an incubator 
at 37°C with a 5% CO2/95% air atmosphere. Smooth muscle cells 
(SMC) grew out from the explants within 2-3 weeks and were subcul- 
tured into 75 cm 2 culture flasks when confluent. Cells were confirmed 
as SMC by their typical 'hill and valley' morphology and positive 
immunofluorescence staining with a monoclonal ntibody against c~- 
actin. SMC between passages 3 and 6 were used in all experiments. 
2.2. Treatment ofsmooth muscle cells with stress agents 
SMC were seeded into 24-well culture plates at a density of 105 
cells/ml 3 days prior to incubation with stress agents. Cells were cul- 
tured in the presence orabsence of the stress agents for 648 h at 37°C 
in a 5% CO2 atmosphere. The final concentrations of tress agents were 
as follows: 100/IM DEM, 2.5-10/tM CdCI2, 5 mU/ml GO and native, 
mildly oxidised or highly oxidised LDL (100 ¢tg protein/ml). Exposure 
to the stress agents was terminated by gently washing the cells twice 
with ice-cold Dulbecco's phosphate buffered saline. Lactate dehydroge- 
nase (LDH) release from porcine SMC was determined toassess the 
viability of cells after the stress treatments. LDH activity was assayed 
in the culture media by using a diagnostic reagent based on the oxida- 
tion of lactate to pyruvate. 
2.3. Western blot analysis 
HO-I and MSP23 protein expression were determined by im- 
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Fig. 1. Time-dependent enhancement of HO-1 (A) and MSP23 (B) expression i  porcine aortic smooth muscle cells exposed to stress agents. Cells 
were incubated for 648 h in the absence (control) or presence of 5 mU/ml glucose oxidase (GO), 10pM CdC12 or 100 pM diethylmaleate (DEM). 
HO-1 and MSP23 expression were determined by Western blot analysis. Data are representative of experiments in 3 different cell cultures. 
munoblotting. SMC proteins were solubilised in buffer (2% sodium 
dodecyl sulphate (SDS), 10% glycerol, 50 mM Tris-HCl, pH 6.8) and 
boiled for 5 min. Sample total protein content was determined using the 
BCA protein assay reagents, and an equal protein concentration from 
each sample was then boiled in a mixture of 1% 2-mercaptoethanol and 
0.05% bromophenol b ue for 3 min. Proteins were separated by SDS- 
polyacrylamide g l electrophoresis u ing a 13% acrylamide resolving 
gel [17]. Separated proteins were then transferred to a polyvinylidine 
difluoride membrane and probed with either a polyclonal rabbit anti- 
rat heme oxygenase antibody [9] or a polyclonal rabbit anti-mouse 
MSP23 antibody [13]. A horseradish peroxidase conjugated goat anti- 
rabbit secondary antibody was used in conjunction with enhanced 
chemiluminescence to visualise the HO-I or MSP23 bands on autoradi- 
ography film. 
2.4. Preparation of LDL 
LDL (density 1.019-1.063 g/ml) was isolated from normal human 
blood by ultracentrifugation in the presence of EDTA, followed by 
dialysis against (mM): NaCI 154, NaH2PO4 16.7, Na2HPO4 21.1, 
EDTA 0.1, pH 7.4, as described previously [18]. Mildly oxidised LDL 
was formed by incubating LDL at 100pg protein/ml at 37°C in (raM): 
NaCI 137, KCI 2.68, NaH2PO 4 8.1, KH2PO 4 1.47, pH 7.4 with CuSO4 
(net concentration 5 pM above the EDTA present). The absorbance at
234 nm was monitored to measure the conjugated dienes produced [19] 
until the absorbance had increased by 0.2.1 mM EDTA was then added 
to stop the oxidation. Highly oxidised LDL was formed by incubating 
the LDL in the above way but for 24 h before adding 1 mM EDTA. 
The density of the oxidised LDL was then raised to 1.2 g/ml with KBr 
(in the presence of Chelex-100) and they were concentrated byultracen- 
trifugation and dialysed against several changes of (mM): NaCl 154, 
NaHzPO4 16.7, NazHPO ~ 21.1, EDTA 1, pH 7.4. They were then 
sterilised by membrane filtration (0.2 pm) and their protein [20] and 
lipid hydroperoxide [21] contents and mobility in agarose gels deter- 
mined. The lipid hydroperoxides in the native, mildly oxidised and 
highly oxidised LDL of the LDLs used were 40, 64 and 80 nmol/mg 
protein respectively and the relative electrophoretic mobilities of 
moxLDL and oxLDL (compared to nLDL) were 1.3 and 4.6 respec- 
tively. 
2.5. Mater&& 
Dulbecco's modified Eagles medium (DMEM), lactate dehydroge- 
nase assay reagent, cadmium chloride and diethylmaleate were pur- 
chased from Sigma Chemical Co., Poole, UK. Glucose oxidase was 
purchased from Calbiochem, Nottingham, UK. Horseradish peroxi- 
dase conjugated goat anti-rabbit immunoglobuin and BCA protein 
assay reagents were purchased from Pierce, Chester, UK. Polyvinylid- 
ine difluoride membrane (Immobilon-P) was purchased from Millipore, 
Watford, UK. Enhanced chemiluminesence W stern blotting detection 
reagents and Hyperfilm-MP autoradiography film were purchased 
from Amersham International, Amersham, UK. All chemicals used 
were of analytical grade. 
3. Results 
Fig. I shows the time-dependent enhanced expression of 
HO- 1 and MSP23 in SMC exposed to GO, DEM or CdCI2. The 
basal expression of HO-1 in SMC was low over the 48 h incu- 
bation period. Expression was enhanced in SMC after 6-12 h 
exposure to 5 mU/ml GO or 100 pM DEM and then decreased 
to basal levels by 48 h (Fig. IA). l0 pM CdC12 did not enhance 
the expression of HO-1 after 6 h but expression was maximal 
by 12 h and remained elevated for 48 h. The basal expression 
of MSP23 was low over the 48 h incubation period. SMC 
exposed to 5 mU/ml GO, 100 pM DEM and 10/ IM CdC12 
showed a marked time-dependent enhancement of MSP23 ex- 
pression, with maximal evels being observed at 48 h (Fig. 1B). 
Maximal expression of HO-1 and MSP23 in SMC treated 
with 100 pM CdCI2 occurred after 24 h and 48 h respectively 
(Fig. 1). As shown in Fig. 2, CdClz (2.5-10 pM) resulted in a 
concentration-dependent hancement of HO-1 and MSP23 
expression. 
HO-1 
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Fig. 2. Concentration-dependent enhancement of HO-1 and MSP23 
expression i porcine aortic smooth muscle cells determined by Western 
blot analysis. Cells were incubated in the absence (control) or presence 
of increasing concentrations of CdC12 (2.5 10 pM) for either 24 h 
(HO-1) or 48 h (MSP23). Data are representative of experiments in
3 different cell cultures. 
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As shown in Fig. 3, these stress proteins were also induced 
in a time-dependent manner following exposure to 100/zg pro- 
tein/ml highly oxidised LDL, a dose shown to produce a max- 
imal response in macrophages [12]. Although the expression of 
either stress protein was not enhanced within 6 h, the levels 
were increased maximally after 24 h. Within 48 h the expression 
of MSP23 had decreased, whereas HO-1 levels were still ele- 
vated. When SMC were incubated with native LDL, mildly 
oxidised LDL or highly oxidised LDL (100/,tg protein/ml) for 
48 h, there was a greater level of HO-1 and MSP23 induction 
with increased LDL oxidation (Fig. 4). 
Release of lactate dehydrogenase into the culture medium of 
cells exposed for 48 h to 5 mU/ml GO, 100/IM DEM, 10 ArM 
CdC12, 100/,tg protein/ml nLDL, moxLDL and oxLDL was 
within 10% of that measured in the medium from control cells, 
indicating that the various stress regimes were not cytotoxic to 
porcine vascular smooth muscle cells (data not shown). 
4. Discussion 
Our study provides the first evidence that expression of the 
antioxidant-like stress proteins HO-1 and MSP23 is enhanced 
in cultured vascular SMC exposed to oxidative stress agents 
and oxidatively modified LDL. These stress-induced proteins 
may play an important role in cellular antioxidant defence 
mechanisms, as antioxidant proteins like MSP23 are able to 
protect enzymatic activity from inactivation by ROS [15], and 
HO-I generates bilirubin, a potent-free radical scavenger [7]. 
HO-1 was acutely induced in the SMC after (~12 h exposure 
to GO, a hydrogen peroxide generator, the electrophilic agent 
DEM and the sulfhydryl-reactive h avy metal cadmium. In 
contrast, MSP23 was only maximally induced after 24~,8 h 
incubation with these stress agents. HO-1 may therefore be 
important in the initial cellular antioxidant response to oxida- 
tive stress, which may then trigger the subsequent induction of 
other cellular antioxidant systems uch as MSP23. 
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Fig. 4. Comparison of the effects of native, mildly oxidised and highly 
oxidised LDL on the expression of HO-I and MSP23 by Western blot 
analysis. Cells were incubated for 48 h in the absence (control) or 
presence of 100/zg protein/ml native, mildly oxidised or highly oxidised 
LDL. Data are representative of experiments in 3 different cell cultures. 
Oxidatively modified LDL has been implicated in the patho- 
genesis of atherosclerosis and may be a major source of free 
radical insult in the arterial wall [22]. HO-I and MSP23 were 
only maximally induced in cultured SMC after 24-48 h incuba- 
tion with oxLDL. In contrast to the early response of HO-1 to 
DEM, GO and cadmium, the delayed responses of HO-1 to 
oxLDL may be due to the different nature of oxidative stress 
presented by oxidatively modified LDLs, including binding to 
SMC LDL receptors [23], transfer of ROS to the plasma mem- 
brane or internalisation of the components of oxidised LDL, 
such as oxysterols and lipid hydroperoxides. Oxidatively mod- 
ified LDL have also been shown to reduce ndothelial cell nitric 
oxide synthesis which may lead to vasoconstriction [24,25]. The 
induction of HO-1 in vascular SMC by oxidatively modified 
LDL may also contribute to the maintenance of arterial pat- 
ency in atherogenesis, as carbon monoxide generated by HO-1 
activity has been shown to stimulate guanylate cyclase activity 
directly [26], which would elevate cGMP production in arterial 
SMC leading to vascular elaxation. 
Our study demonstrates that vascular SMC induce protective 
responses to oxidative stress and oxidatively modified LDLs. 
Further understanding of the regulation of these responses and 
their sensitivity to dietary antioxidants could lead to alternative 
strategies for reducing atherogenesis, 
Acknowledgements: This work was supported in part by the Ministry 
of Agriculture, Fisheries and Food Antioxdiant Research Initiative, 
Japanese Ministry of Education, Science and Culture and a British 
Council Collaborative Research Link, including a 1-year esearch fel- 
lowship for Dr, H. Sato at King's College London. We thank Mr. Justin 
E Richards for his skilled assistance in preparing the oxidatively mod- 
ified LDL. 
(B) MSP23 
Control 
oxLDL 
6 12 24 48 
Incubation time (11) 
Fig. 3. Time-dependent enhancement of HO-I (A) and MSP23 (B) 
expression in porcine aortic smooth muscle cells exposed to oxLDL 
determined by Western blot analysis. Cells were incubated for 648 h 
in the absence (control) or presence of 100/~g protein/ml oxLDL. Data 
are representative of experiments in 3 different cell cultures. 
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